Inactive Instrument

Johnson & Johnson Share Price Buenos Aires S.E.

Equities

DJNJ3D

ARDEUT112687

Pharmaceuticals

End-of-day quote Buenos Aires S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
1,153 ARS -.--% Intraday chart for Johnson & Johnson -1.28% +0.26%

Financials

Sales 2024 * 88.37B 78,120B 7,039B Sales 2025 * 90.78B 80,250B 7,231B Capitalization 364B 321,721B 28,991B
Net income 2024 * 22.04B 19,482B 1,756B Net income 2025 * 23.09B 20,413B 1,839B EV / Sales 2024 * 4.04 x
Net cash position 2024 * 7B 6,185B 557B Net cash position 2025 * 21.07B 18,630B 1,679B EV / Sales 2025 * 3.78 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
15.9 x
Employees 131,900
Yield 2024 *
3.19%
Yield 2025 *
3.33%
Free-Float 77.07%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Johnson & Johnson

Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change Volume
10/05/24 1,210 +0.41% 3
07/05/24 1,205 +0.42% 9

End-of-day quote Buenos Aires S.E., April 25, 2024

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company